53472-18-7Relevant articles and documents
Merging Photoredox Catalysis with Iron(III) Catalysis: C5-H Bromination and Iodination of 8-Aminoquinoline Amides in Water
Qiao, Huijie,Sun, Suyan,Yang, Fan,Zhu, Yu,Kang, Jianxun,Wu, Yusheng,Wu, Yangjie
, p. 1976 - 1980 (2017)
A simple and efficient protocol for the iron(III)-catalyzed C5 halogenation of 8-aminoquinoline with potassium halides via a photoredox process was developed, affording desired products in good to excellent yields. This reaction features its mild and gree
Visible light-induced mono-bromination of arenes with BrCCl3
Fan, Jiali,Wei, Qiancheng,Zhu, Ershu,Gao, Jing,Cheng, Xiamin,Lu, Yongna,Loh, Teck-Peng
supporting information, p. 5977 - 5980 (2021/06/18)
A highly efficient and regioselective bromination of electron-rich arenes and heteroarenes using commercially available BrCCl3as a “Br” source has been developed. The reaction was performed in air under mild conditions with photocatalyst Ru(bpy)3Cl2·6H2O, avoiding the usage of strong acids and strong oxidants. Mono-brominated products were obtained with medium to excellent yields (up to 94%). This strategy has shown good compatibility and highpara-selectivity, which will facilitate the complicated synthesis.
New compound used as rearranged during transfection kinase inhibitor
-
, (2021/03/05)
The present invention relates to a compound, a pharmaceutical composition containing the compound, a preparation method of the compounds, and application of the same as a rearranged during transfection (RET) kinase inhibitor. The compound is a compound shown as formula (I), or a pharmaceutically acceptable salt, a prodrug, a solvent compound, a polymorph, an isomer and a stable isotope derivativethereof. The present invention also relates to the application of the compounds to treatment or prevention of RET kinase mediated related diseases like tumors and a method of using the compounds for the treatment of the diseases.